EP2854768 - Bibliographic data
COMPOSITIONS PHARMACEUTIQUES DE PEMETREXED
Last update | 06/07/2025 |
---|---|
Legal status | Brevet déchu |
Origin | Euro-PCT |
(73) Holder |
Fresenius Kabi Oncology Limited B- 310, Som Datt Chambers - I
Bhikaji Cama Place
New Delhi 110 066
Inde
|
---|---|
(72) Inventors |
Dhiraj KHATTAR Fresenius Kabi Oncology Limited
Echelon Institutional Area
Plot No - 11 Sector-32
Haryana
Gurgaon 122 001
Inde
Rajesh KHANNA Fresenius Kabi Oncology Limited
Echelon Institutional Area
Plot No - 11 Sector-32
Haryana
Gurgaon 122 001
Inde
Mukti YADAV Fresenius Kabi Oncology Limited
Echelon Institutional Area
Plot No - 11 Sector-32
Haryana
Gurgaon 122 001
Inde
Krishanu BURMAN Fresenius Kabi Oncology Limited
Echelon Institutional Area
Plot No - 11 Sector-32
Haryana
Gurgaon 122 001
Inde
|
(74) Agent |
Mail recipient Fresenius Kabi Deutschland GmbH Patent Department
Borkenberg 14
61440 Oberursel
Allemagne
|
(21) Request number | EP13730070.3 |
---|---|
(22) Request date | 30/05/2013 |
(11) Publication number | EP2854768 |
---|---|
Publication date | 22/03/2017 |
(54) Title of the invention | COMPOSITIONS PHARMACEUTIQUES DE PEMETREXED |
---|---|
(51) International classification | A61K 9/08, A61K 9/19, A61K 47/18, A61K 31/519, A61P 35/00 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 1648DE2012 |
---|---|
Initial application | None |
Divisional application | EP17161417.5 /EP3210629 None |
Expected annuity |
Annuity: 5 -
Amount: 55 € -
Due date 31/05/2017
Surtax: 5 - Amount: 11 € - Due date 01/12/2017 |
---|---|
Last annuity | None |
Publication | None |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 22/03/2017 Modification des informations de priorité du brevet européen - Legal date 17/03/2017 Entrée en période de grâce du brevet d'invention - Legal date 01/06/2017 Déchéance du brevet d'invention après période de grâce - Legal date 31/05/2017 |